Senfeng Xiang

569 total citations
12 papers, 406 citations indexed

About

Senfeng Xiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Senfeng Xiang has authored 12 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Senfeng Xiang's work include Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Protein Degradation and Inhibitors (3 papers). Senfeng Xiang is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Protein Degradation and Inhibitors (3 papers). Senfeng Xiang collaborates with scholars based in China and Belgium. Senfeng Xiang's co-authors include Qiaojun He, Ji Cao, Meidan Ying, Xuejing Shao, Bo Yang, Qian Zhou, Bo Yang, Hong Zhu, Yingqian Chen and Miao Xian and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Senfeng Xiang

11 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Senfeng Xiang China	8	237	137	132	94	93	12	406
Maria A. Voronkova United States	9	280 1.2×	119 0.9×	91 0.7×	114 1.2×	56 0.6×	15	452
Annabelle Chow Canada	12	185 0.8×	168 1.2×	88 0.7×	101 1.1×	72 0.8×	17	398
Erin D. Lucas Australia	8	163 0.7×	125 0.9×	160 1.2×	73 0.8×	25 0.3×	9	372
Benyoussef Naïmi France	9	317 1.3×	119 0.9×	92 0.7×	95 1.0×	63 0.7×	10	390
Marta Popęda Poland	13	156 0.7×	142 1.0×	52 0.4×	87 0.9×	79 0.8×	32	350
Kazuaki Fushimi Japan	15	333 1.4×	135 1.0×	52 0.4×	131 1.4×	68 0.7×	22	486
Michael M. Allevato United States	7	178 0.8×	145 1.1×	79 0.6×	61 0.6×	56 0.6×	15	336
Jingde Chen China	10	279 1.2×	90 0.7×	44 0.3×	128 1.4×	78 0.8×	21	370
Brian DeCant United States	10	227 1.0×	295 2.2×	107 0.8×	87 0.9×	25 0.3×	13	458
Irina Abécassis United States	6	147 0.6×	186 1.4×	154 1.2×	80 0.9×	41 0.4×	7	371

Countries citing papers authored by Senfeng Xiang

Since Specialization

Citations

This map shows the geographic impact of Senfeng Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Senfeng Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Senfeng Xiang more than expected).

Fields of papers citing papers by Senfeng Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Senfeng Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Senfeng Xiang. The network helps show where Senfeng Xiang may publish in the future.

Co-authorship network of co-authors of Senfeng Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Senfeng Xiang. A scholar is included among the top collaborators of Senfeng Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Senfeng Xiang. Senfeng Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Xiang, Senfeng, Pengfei Chen, Haoyang Cai, et al.. (2025). Disruption of the KLHL37–N-Myc complex restores N-Myc degradation and arrests neuroblastoma growth in mouse models. Journal of Clinical Investigation. 135(14).

Xian, Miao, Jiayi Liu, Xiaomin Wang, et al.. (2024). Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation. Nature Communications. 15(1). 9820–9820. 7 indexed citations

Xiang, Senfeng, Yilong Wang, Zhonghai Guan, et al.. (2023). AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells. Acta Pharmaceutica Sinica B. 13(4). 1522–1536. 5 indexed citations

Xiang, Senfeng, Xuejing Shao, Ji Cao, et al.. (2022). Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells. Acta Pharmacologica Sinica. 44(3). 661–669. 11 indexed citations

Xiang, Senfeng, et al.. (2022). Kelch-like proteins in the gastrointestinal tumors. Acta Pharmacologica Sinica. 44(5). 931–939. 7 indexed citations

Xiang, Senfeng, Pengfei Chen, Ji Cao, et al.. (2021). Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy. Pharmacological Research. 169. 105616–105616. 10 indexed citations

Xiang, Senfeng, Ji Cao, Hong Zhu, et al.. (2019). Kelch-like proteins: Physiological functions and relationships with diseases. Pharmacological Research. 148. 104404–104404. 55 indexed citations

Shao, Xuejing, Senfeng Xiang, Huarui Fu, et al.. (2019). CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells. Pharmacological Research. 151. 104545–104545. 14 indexed citations

Shao, Xuejing, Senfeng Xiang, Yingqian Chen, et al.. (2019). Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells. Acta Pharmacologica Sinica. 40(10). 1343–1350. 75 indexed citations

10.

Xiang, Senfeng, et al.. (2019). FAT10: Function and Relationship with Cancer. Current Molecular Pharmacology. 13(3). 182–191. 21 indexed citations

11.

Ying, Meidan, Xuejing Shao, Hui Jing, et al.. (2018). Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2. Blood. 131(24). 2698–2711. 80 indexed citations

12.

Zhou, Qian, Miao Xian, Senfeng Xiang, et al.. (2017). All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages. Cancer Immunology Research. 5(7). 547–559. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact